COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

Document first published:
Page updated:
Topic:
Publication type:

Guidance on the use of systemic corticosteroids in patients with severe and critical COVID-19 disease.

This letter also confirms that they should not be used in patients with non-severe COVID-19.

Summary

Letter from Dr Keith Ridge CBE, Chief Pharmaceutical Officer, and Professor Stephen Powis, NHS National Medical Director.

Published 13 November 2020.